Nippon Shinyaku

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Nippon Shinyaku's Japan sales performance.

Lilly links up with Precision BioSciences in genome editing deal

In August, the US Food and Drug Administration (FDA) approved Japanese pharmaceutical company Nippon Shinyaku’s (NS Pharma) DMD drug Viltepso (viltolarsen).

FDA approves Sarepta rival NS Pharma’s Duchenne drug

Drug approved for patients with exon 53 mutation. Japanese pharma Nippon Shinyaku (NS Pharma) has scored US Food and Drug Administration (FDA) approval for its Duchenne muscular dystrophy drug viltolarsen, now

FDA sets Q3 decision date for NS Pharma’s DMD drug

NS Pharma and its parent company Nippon Shinyaku are currently enrolling patients for a phase 3 study in Japan and the US – named RACER53.

Wave’s challenge to Sarepta in Duchenne falls flat

The demise of Wave’s programmes leaves Japan’s Nippon Shinyaku Pharma as the main rival to Sarepta in DMD.

Solid Bio falls as FDA halts DMD trial over safety concerns

In the meantime, rival candidate viltolarsen from Japanese pharma Nippon Shinyaku (NS Pharma) has been filed with the FDA for the treatment of DMD.

1 2 3 4 [ Next 5 results ]

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology

COVID-19 Updates and Daily News

Featured jobs

SENIOR MEDICAL WRITER: Salary TBC

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

SENIOR ACCOUNT MANAGER - MEDICAL COMMUNICATIONS: Salary TBC

Senior Account Director - Med Comms Agency: Salary TBC

MEDICAL WRITER - HOME WORKING: Salary TBC

ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER: Salary TBC

#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?: Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
Good design saves lives: Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies: Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...